Dianthus Therapeutics, Inc. Stock Forecast
Dianthus Therapeutics, Inc. stock price took a fall of -5.02% on Tuesday
(Updated on Jun 25, 2024)
The Dianthus Therapeutics, Inc. stock price fell by -5.02% on the last day (Tuesday, 25th Jun 2024) from $25.52 to $24.24. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 7.14% from a day low at $24.24 to a day high of $25.97. The price has fallen in 6 of the last 10 days but is still up by 12.93% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -77 thousand shares and in total, 180 thousand shares were bought and sold for approximately $4.36 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -8.82% during the next 3 months and, with a 90% probability hold a price between $17.58 and $24.41 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
DNTH Signals & Forecast
The Dianthus Therapeutics, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $25.33. On a fall, the stock will find some support from the long-term average at approximately $24.01. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, May 14, 2024, and so far it has fallen -13.24%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Dianthus Therapeutics, Inc. stock
Dianthus Therapeutics, Inc. finds support from accumulated volume at $23.24 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.73 between high and low, or 7.14%. For the last week, the stock has had daily average volatility of 7.58%.
Our recommended stop-loss: $22.82 (-5.84%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 41 days ago.)
Trading Expectations (DNTH) For The Upcoming Trading Day Of Wednesday 26th
For the upcoming trading day on Wednesday, 26th we expect Dianthus Therapeutics, Inc. to open at $24.82, and during the day (based on 14 day Average True Range), to move between $22.39 and $26.09, which gives a possible trading interval of +/-$1.85 (+/-7.65%) up or down from last closing price. If Dianthus Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 15.30% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $24.88 (2.64%) than the support at $23.24 (4.13%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Dianthus Therapeutics, Inc. stock A Buy?
Dianthus Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score: -0.837 Hold/Accumulate Unchanged
Predicted Opening Price for Dianthus Therapeutics, Inc. of Wednesday, June 26, 2024
Fair opening price June 26, 2024 | Current price |
---|---|
$24.82 ( 2.38%) | $24.24 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for DNTH
Fibonacci Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 26.55 | 9.52% |
R2 | 25.89 | 6.79% |
R1 | 25.48 | 5.11% |
Price | 24.24 | |
S1 | 24.16 | -0.347% |
S2 | 23.75 | -2.03% |
S3 | 23.09 | -4.76% |
Accumulated Volume Support & Resistance Levels
Level | Price | |
---|---|---|
R3 | 25.53 | 5.32% |
R2 | 25.26 | 4.21% |
R1 | 24.88 | 2.64% |
Price | 24.24 | |
S1 | 23.24 | -4.13% |
S2 | 21.77 | -10.19% |
S3 | 21.47 | -11.45% |
FAQ
Click here for our free guide on how to buy Dianthus Therapeutics, Inc. Stock.